SPAC Insiders Who Sold at the Top
While retail investors held and hoped, SPAC insiders sold. SEC Form 4 filings โ which insiders must file within two business days of a stock transaction โ tell a damning story. Sponsors, directors, and executives across dozens of de-SPAC companies liquidated hundreds of millions of dollars in shares near peak prices, often before the businesses reported their first set of disappointing earnings.
The Selling Pattern
Insider selling in de-SPAC companies followed a remarkably consistent pattern: shares were locked up for 30-180 days after the merger close. The moment the lock-up expired, insiders sold aggressively โ often through pre-arranged 10b5-1 trading plans that provided legal cover. The sales typically occurred while the company was still in its post-merger "honeymoon" phase, before the gap between projections and reality became undeniable.
Named Insiders and Documented Sales
| Insider | Company (SPAC) | Shares Sold | Approx. Proceeds | Stock Price Today |
|---|---|---|---|---|
| Chamath Palihapitiya | Virgin Galactic (IPOA) | 6.2M shares | $213M | $1.30 (-95%) |
| Chamath Palihapitiya | Clover Health (IPOC) | Entire personal stake | $~80M | $0.80 (-92%) |
| Trevor Milton | Nikola (VTIQ) | ~3.5M shares | $~70M pre-indictment | $0.67 (-97%) |
| Reid Hoffman | Joby Aviation (RTP) | 7.5M shares | $~75M | $4.50 (-55%) |
| Michael Klein | MultiPlan (CFAC) | Sponsor shares sold | $~140M | $0.18 (-98%) |
Chamath's Exit:Palihapitiya sold his entire personal stake in Clover Health in early 2021 for approximately $80M, then sold 6.2 million Virgin Galactic shares for $213M โ disclosing the sales through SEC filings that received minimal media attention at the time. Both stocks subsequently lost over 90% of their value. He described the sales as "portfolio rebalancing."
The Lock-Up Expiration Cascade
SPAC merger agreements typically include lock-up provisions preventing insiders from selling for 30-180 days. These lock-ups were supposed to align insider and shareholder interests. In practice, they just delayed the selling. SEC filings show that within 30 days of lock-up expiration, insiders at the average de-SPAC sold 15-25% of their holdings. Within 90 days, that number rose to 40-60%.
The stock market response was predictable. An academic study by Klausner, Ohlrogge, and Ruan found that de-SPAC stocks dropped an average of 8-12% in the two weeks surrounding lock-up expirations, as the market anticipated and absorbed insider selling pressure.
The 10b5-1 Shield
Many insiders used Rule 10b5-1 pre-arranged trading plans as legal protection. These plans, supposedly set up in advance to avoid insider trading allegations, allowed executives to sell on autopilot. But the timing was suspicious: several SPAC insiders adopted 10b5-1 plans shortly after the merger closed, set to begin selling immediately upon lock-up expiration โ the earliest possible moment.
The SEC tightened 10b5-1 rules in 2023, requiring a 90-day cooling-off period before sales could begin and limiting the use of multiple overlapping plans. But the damage was already done: billions in insider sales had occurred during 2021-2022, the peak of the SPAC bust.
The Retail Bag-Holders
While insiders sold, retail investors held. Vanda Research data shows that retail investors were net buyers of de-SPAC stocks throughout 2021 and into 2022 โ even as insiders were net sellers. The information asymmetry was staggering: insiders had board-level visibility into deteriorating fundamentals, while retail investors relied on the same bullish projections from the merger proxy.
The legal reality: Almost none of these insider sales were illegal. SEC disclosure requirements were followed. Lock-up provisions were honored. Trading plans were filed. The system worked exactly as designed โ which is the problem. The system was designed to let insiders sell legally while retail investors lacked the information and sophistication to recognize the signal.
| Company | Insider Sales (First 6 Months) | Stock Decline (First Year) | Retail Net Buying |
|---|---|---|---|
| Virgin Galactic | $350M+ | -72% | $180M net inflow |
| Nikola | $280M+ | -85% | $420M net inflow |
| QuantumScape | $450M+ | -78% | $310M net inflow |
| Lordstown | $~30M (DOJ investigated) | -94% | $95M net inflow |
| Clover Health | $~150M | -88% | $260M net inflow |
All insider sale amounts from SEC Form 4 filings, sourced via OpenInsider and SEC EDGAR. Retail flow data from Vanda Research. Updated March 2026.